NCT01125631View on ClinicalTrials.gov

Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Alzheimer's Disease
Interventions
BIOLOGICAL

PF-04360365 8.5 mg/kg

8.5 mg/kg every 8 weeks (4 doses total)

DRUG

Placebo

Placebo every 8 weeks (4 doses total)

Trial Locations (4)

Unknown

Pfizer Investigational Site, Hirosaki

Pfizer Investigational Site, Fukuoka

Pfizer Investigational Site, Fukuyama

Pfizer Investigational Site, Kanazawa

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY